Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus

被引：67

作者：

Playford, DA ^{[1
]}

Watts, GF ^{[1
]}

Best, JD ^{[1
]}

Burke, V ^{[1
]}

机构：

[1] Univ Western Australia, Royal Perth Hosp, Dept Med, Perth, WA 6847, Australia

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2002年 / 90卷 / 11期

关键词：

D O I：

10.1016/S0002-9149(02)02847-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Forty patients with type 2 diabetes and dyslipidemia were randomized in a double-blind study to receive fenofibrate or placebo for 12 weeks. Brachial artery flow-mediated dilatation improved in response to fenofibrate but not placebo, with changes partly related to improvements in plasma lipid and lipoprotein concentrations.

引用

页码：1254 / +

页数：5

共 21 条

[1] The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes [J].

Anderson, RA ;

Evans, ML ;

Ellis, GR ;

Graham, J ;

Morris, K ;

Jackson, SK ;

Lewis, MJ ;

Rees, A ;

Frenneaux, MP .

ATHEROSCLEROSIS, 2001, 154 (02) :475-483

[2] Effect of gemfibrozil +/- niacin +/- cholestyramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels <160 mg/dl and high-density lipoprotein cholesterol levels <40 mg/dl [J].

Andrews, TC ;

Whitney, EJ ;

Green, G ;

Kalenian, R ;

Personius, BE .

AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (07) :831-835

[3] Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients [J].

Avogaro, A ;

Miola, M ;

Favaro, A ;

Gottardo, L ;

Pacini, G ;

Manzato, E ;

Zambon, S ;

Sacerdoti, D ;

de Kreutzenberg, S ;

Piliego, T ;

Tiengo, A ;

Del Prato, S .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2001, 31 (07) :603-609

[4] ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION - BEYOND NITRIC-OXIDE AND CYCLIC-GMP [J].

COHEN, RA ;

VANHOUTTE, PM .

CIRCULATION, 1995, 92 (11) :3337-3349

[5] Endothelial dysfunction in diabetes [J].

De Vriese, AS ;

Verbeuren, TJ ;

Van de Voorde, J ;

Lameire, NH ;

Vanhoutte, PM .

BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (05) :963-974

[6] Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients [J].

Ericsson, CG ;

Hamsten, A ;

Nilsson, J ;

Grip, L ;

Svane, B ;

deFaire, U .

LANCET, 1996, 347 (9005) :849-853

[7] Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus [J].

Evans, M ;

Anderson, RA ;

Graham, J ;

Ellis, GR ;

Morris, K ;

Davies, S ;

Jackson, SK ;

Lewis, MJ ;

Frenneaux, MP ;

Rees, A .

CIRCULATION, 2000, 101 (15) :1773-1779

[8] Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis [J].

Fruchart, JC ;

Duriez, P ;

Staels, B .

CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (03) :245-257

[9] NITRIC-OXIDE IS RESPONSIBLE FOR FLOW-DEPENDENT DILATATION OF HUMAN PERIPHERAL CONDUIT ARTERIES IN-VIVO [J].

JOANNIDES, R ;

HAEFELI, WE ;

LINDER, L ;

RICHARD, V ;

BAKKALI, EH ;

THUILLEZ, C ;

LUSCHER, TF .

CIRCULATION, 1995, 91 (05) :1314-1319

[10] An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography mass spectrometry [J].

Mori, TA ;

Croft, KD ;

Puddey, IB ;

Beilin, LJ .

ANALYTICAL BIOCHEMISTRY, 1999, 268 (01) :117-125

← 1 2 3 →